Understanding AI and Patent Eligibility
In this episode of Knobbe IP+, Knobbe Martens partners Jarom Kesler and Bryan McWhorter discuss the latest developments in AI and patent eligibility. Sharing insights for both fellow IP practitioners and...
No “Duty to Innovate” – California’s Highest Court Finds Gilead Sciences Not Negligent for Delaying Release of Allegedly Safer HIV Drug
Key Takeaway: California court holds that drug manufacturers do not have a duty to commercialize a safer drug to replace a nondefective one. In the Gilead Tenofovir Cases, a group...
Typos Cause Alkanes of Trouble
ENCANTA PHARMACEUTICALS, INC. v. PFIZER INC. Before Lourie, Bryson, and Chen. Appeal from the United States District Court for the District of Massachusetts. Summary: A patentee could not argue that...